Biopharmaceuticals

Browse venture capital firms focused on Biopharmaceuticals.

Explore VC firms that invest in Biopharmaceuticals. Filter by country and stage to refine results.

4 of 1000 firms
Filters:
5AM Ventures favicon
5AM Ventures
United States

5AM Ventures is a leading life science venture capital firm focused on funding and building next-generation life sciences companies. They primarily invest in early-stage private therapeutic companies, with an emphasis on Series A, and also invest in small and mid-cap public and later-stage private biotech and life science companies.

Founded 2002
Investment Stages
Seed
Series A
Series B
Markets
Biopharmaceuticals
drug delivery technologies
life science instruments
Axil Capital favicon
Axil Capital
Japan

Axil Capital is a venture capital firm specializing in biomedical and healthcare technology investments. They focus on supporting the growth of early-stage ventures and leveraging their global network to create synergies between the Japanese and global biotech ecosystems. Their investments span the full spectrum of the life science industry, from seed to crossover rounds.

Founded 2017
Investment Stages
Series A
Series B
Markets
Biopharmaceuticals
Platform technologies
Medical devices
Digital health
Healthcare services
Artificial Intelligence (AI)
Pharmaceutical
Robotics
Fountain Healthcare Partners favicon
Fountain Healthcare Partners
Ireland, United States

Fountain Healthcare Partners is a venture fund providing risk capital and expertise to life sciences companies. They focus on a limited number of portfolio companies to provide extensive support beyond capital, acting as true partners in growth and risk mitigation. Their investments span from seed stage to public offerings, with a majority in Europe and the remainder in the US.

Founded 2008
Investment Stages
Seed
Series A
Series B
Markets
Specialty Pharma
Biopharmaceuticals
Medical Devices
Diagnostics
Jeito Capital favicon
Jeito Capital
France

Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.

Founded 2018
Investment Stages
Series A
Series B
Markets
Biopharmaceuticals
Oncology
Ophthalmology
Rare Skeletal Diseases
Severe Respiratory Diseases
Fibrosis
Immuno-oncology
Cardiovascular Disease
Immuno-Oncology Therapies
Auto-Immune Diseases
Neuromuscular Diseases
Cell Therapy
Gene Therapy